Autopsy report · NCT00255268
CMAB vs IMAB in Metastatic Prostate Cancer
Cause of deathNo reason given
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Metastatic Prostate Cancer
- Interventions
- Goserelin; Bicalutamide
- Participants
- 15 (planned, not actual)
- Sites
- 2
- Countries
- Mexico
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.